We are live on
!
Find out more
IP
Intellectus Partners Portfolio holdings
AUM
$578M
Turnover
15.36%
1-Year Est. Return
49.48%
This Fund
S&P 500
This Quarter
Est. Return
+17.57%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$26.6M
(+11%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
27.49%
Holding
835
New
43
Increased
126
Reduced
128
Closed
212
Avg Time Held Equity + Options
0.8
years
Top 10 Avg Time Held Equity + Options
0.7
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.7
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xunlei
XNET
|
+$7.61M |
| 2 |
Baidu
BIDU
|
+$2.31M |
| 3 |
Invesco Preferred ETF
PGX
|
+$1.46M |
| 4 |
WUBA
58.com Inc
WUBA
|
+$1.46M |
| 5 |
FEI
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Consumer Discretionary ETF
VCR
|
+$838K |
| 2 |
SIGM
Sigma Designs Inc
SIGM
|
+$617K |
| 3 |
Viasat
VSAT
|
+$595K |
| 4 |
Meta Platforms (Facebook)
META
|
+$584K |
| 5 |
Ralph Lauren
RL
|
+$436K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Miscellaneous | 21.58% |
| 3 | Communication Services | 13.79% |
| 4 | Healthcare | 11.55% |
| 5 | Financials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Edwards Lifesciences
EW
$49.8B
| $14K | 0.01% |
372
| – | – |
2016 Q4
4 quarters
|
|
452
Ingevity
NGVT
$2.41B
| $14K | 0.01% |
200
| – | – |
2016 Q4
4 quarters
|
|
|
FCRD
453
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $14K | 0.01% |
1,537
+44
| +3% | +$407 |
2017 Q3
1 quarter
|
|
|
AGN
454
CALL
DELISTED
Allergan plc
AGN
| $14K | 0.01% |
+800
| New | +$144K |
2017 Q4
0 quarters
|
|
455
Hilton Worldwide
HLT
$73.8B
| $13K | ﹤0.01% |
166
| – | – |
2017 Q1
3 quarters
|
|
456
Liberty Global Class C
LBTYK
$2.74B
| $13K | ﹤0.01% |
396
| – | – |
2016 Q4
4 quarters
|
|
457
Lear
LEA
$5.89B
| $13K | ﹤0.01% |
71
| – | – |
2016 Q4
4 quarters
|
|
458
Olin
OLN
$1.71B
| $13K | ﹤0.01% |
377
| – | – |
2016 Q4
4 quarters
|
|
459
CBRE Group
CBRE
$37.3B
| $12K | ﹤0.01% |
285
| – | – |
2017 Q2
2 quarters
|
|
460
iShares Russell 1000 Value ETF
IWD
$83.1B
| $12K | ﹤0.01% |
100
-100
| -50% | -$12.1K |
2016 Q4
4 quarters
|
|
461
DELISTED
ODP
ODP
| $12K | ﹤0.01% |
342
| – | – |
2016 Q4
4 quarters
|
|
462
Rambus
RMBS
$9.99B
| $12K | ﹤0.01% |
874
| – | – |
2016 Q4
4 quarters
|
|
463
Socket Mobile
SCKT
$3.87M
| $12K | ﹤0.01% |
3,419
-2,000
| -37% | -$7.25K |
2016 Q4
4 quarters
|
|
464
Vipshop
VIPS
$6.11B
| $12K | ﹤0.01% |
1,023
| – | – |
2017 Q3
1 quarter
|
|
465
Niagen Bioscience
NAGE
$200M
| $12K | ﹤0.01% |
+2,000
| New | +$10.8K |
2017 Q4
0 quarters
|
|
|
CCLP
466
DELISTED
CSI Compressco LP
CCLP
| $12K | ﹤0.01% |
2,209
+73
| +3% | +$380 |
2017 Q2
2 quarters
|
|
467
Bank of New York Mellon
BNY
$93.4B
| $11K | ﹤0.01% |
207
| – | – |
2016 Q4
4 quarters
|
|
468
Celldex Therapeutics
CLDX
$2.19B
| $11K | ﹤0.01% |
267
| – | – |
2016 Q4
4 quarters
|
|
469
Eastman Chemical
EMN
$7.19B
| $11K | ﹤0.01% |
121
| – | – |
2017 Q2
2 quarters
|
|
470
Fortinet
FTNT
$135B
| $11K | ﹤0.01% |
1,300
| – | – |
2017 Q3
1 quarter
|
|
471
iShares 7-10 Year Treasury Bond ETF
IEF
$41.4B
| $11K | ﹤0.01% |
100
| – | – |
2017 Q2
2 quarters
|
|
472
DELISTED
Liberty Broadband Class C
LBRDK
| $11K | ﹤0.01% |
133
| – | – |
2016 Q4
4 quarters
|
|
473
Labcorp
LH
$25.7B
| $11K | ﹤0.01% |
81
| – | – |
2017 Q2
2 quarters
|
|
474
Lumen Technologies, Inc. Common Stock
LUMN
$4.69B
| $11K | ﹤0.01% |
642
+492
| +328% | +$8.34K |
2017 Q2
2 quarters
|
|
475
Phio Pharmaceuticals
PHIO
$11M
| – | – |
0
| – | – |
2017 Q4
0 quarters
|
|
Similar funds
AFGAS
RWM
AHL
CTAF
HIM
SSP
CA
PWM
Intellectus Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Intellectus Partners held 835 positions worth $268M, up 11% from $241M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Intellectus Partners deployed $11.2M of net new capital in Q4 2017, opening 43 new positions and adding to 126 existing holdings. Its largest new stake was Xunlei: 662,985 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Vanguard Consumer Discretionary ETF, an estimated $838K trimmed.
- Intellectus Partners's largest Q4 2017 buy was Xunlei: 662,985 shares worth $10.2M.
- Intellectus Partners added most to Baidu in Q4 2017, an estimated $2.31M increase.
- Intellectus Partners's biggest Q4 2017 reduction was Vanguard Consumer Discretionary ETF, cutting an estimated $838K.
- Intellectus Partners fully exited Viasat in Q4 2017, selling an estimated $595K.
- Intellectus Partners's ten largest holdings make up 27% of its $268M portfolio in Q4 2017.
- Intellectus Partners opened 43 new positions and closed 212 in Q4 2017.
- Intellectus Partners's portfolio value rose 11% quarter-over-quarter to $268M.
Based on Intellectus Partners's 13F filing for Q4 2017, filed 13 Feb 2018.